Literature DB >> 24452542

The two faces of vaccine-induced immune response: protection or increased risk of HIV infection?!

Vladimir Temchura1, Matthias Tenbusch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24452542      PMCID： PMC8206376          DOI： 10.1007/s12250-014-3419-9

Source DB:  PubMed          Journal:  Virol Sin        ISSN： 1995-820X            Impact factor:   4.327


× No keyword cloud information.
  28 in total

1.  Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.

Authors:  Katherine Masek-Hammerman; Hualin Li; Jinyan Liu; Peter Abbink; Annalena La Porte; Kara L O'Brien; James B Whitney; Angela Carville; Keith G Mansfield; Dan H Barouch
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 2.  Quiescent T cells and HIV: an unresolved relationship.

Authors:  Dimitrios N Vatakis; Christopher C Nixon; Jerome A Zack
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

3.  HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.

Authors:  Damien Z Soghoian; Heiko Jessen; Michael Flanders; Kailan Sierra-Davidson; Sam Cutler; Thomas Pertel; Srinika Ranasinghe; Madelene Lindqvist; Isaiah Davis; Kimberly Lane; Jenna Rychert; Eric S Rosenberg; Alicja Piechocka-Trocha; Abraham L Brass; Jason M Brenchley; Bruce D Walker; Hendrik Streeck
Journal:  Sci Transl Med       Date:  2012-02-29       Impact factor: 17.956

4.  HIV preferentially infects HIV-specific CD4+ T cells.

Authors:  Daniel C Douek; Jason M Brenchley; Michael R Betts; David R Ambrozak; Brenna J Hill; Yukari Okamoto; Joseph P Casazza; Janaki Kuruppu; Kevin Kunstman; Steven Wolinsky; Zvi Grossman; Mark Dybul; Annette Oxenius; David A Price; Mark Connors; Richard A Koup
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

5.  Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain.

Authors:  Maria E Moreno-Fernandez; Wildeman Zapata; Jason T Blackard; Genoveffa Franchini; Claire A Chougnet
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

6.  Immunogenicity of DNA vaccines encoding simian immunodeficiency virus antigen targeted to dendritic cells in rhesus macaques.

Authors:  Matthias Tenbusch; Ralf Ignatius; Godwin Nchinda; Christine Trumpfheller; Andres M Salazar; Katharina Töpfer; Ulrike Sauermann; Ralf Wagner; Drew Hannaman; Klara Tenner-Racz; Paul Racz; Christiane Stahl-Hennig; Klaus Uberla
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

7.  A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy.

Authors:  Federica Crostarosa; Meropi Aravantinou; Onome J Akpogheneta; Edith Jasny; Andrew Shaw; Jessica Kenney; Michael Piatak; Jeffrey D Lifson; Aaron Teitelbaum; Lieyu Hu; Anne Chudolij; Thomas M Zydowsky; James Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

8.  T cell independent secondary antibody responses to the envelope protein of simian immunodeficiency virus.

Authors:  Ghulam Nabi; Vladimir Temchura; Claudius Grossmann; Seraphin Kuate; Matthias Tenbusch; Klaus Überla
Journal:  Retrovirology       Date:  2012-05-14       Impact factor: 4.602

Review 9.  HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection?

Authors:  Klaus Uberla
Journal:  PLoS Pathog       Date:  2008-08-29       Impact factor: 6.823

10.  The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

Authors:  Rafick-Pierre Sekaly
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307
View more
  4 in total

1.  Binding of HIV-1 virions to α4β 7 expressing cells and impact of antagonizing α4β 7 on HIV-1 infection of primary CD4+ T cells.

Authors:  Chang Li; Wei Jin; Tao Du; Biao Wu; Yalan Liu; Robin J Shattock; Qinxue Hu
Journal:  Virol Sin       Date:  2014-12-10       Impact factor: 4.327

2.  Interaction of viruses with host immune system and immunomodulation in chronic viral infections.

Authors:  Mengji Lu; Yumei Wen
Journal:  Virol Sin       Date:  2014-02       Impact factor: 4.327

3.  Calcium Phosphate Nanoparticle-Based Vaccines as a Platform for Improvement of HIV-1 Env Antibody Responses by Intrastructural Help.

Authors:  Dominik Damm; Leonardo Rojas-Sánchez; Hannah Theobald; Viktoriya Sokolova; Richard T Wyatt; Klaus Überla; Matthias Epple; Vladimir Temchura
Journal:  Nanomaterials (Basel)       Date:  2019-09-27       Impact factor: 5.076

4.  Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper Liposomes.

Authors:  Dominik Damm; Ehsan Suleiman; Hannah Theobald; Jannik T Wagner; Mirjam Batzoni; Bianca Ahlfeld Née Kohlhauser; Bernd Walkenfort; Jens-Christian Albrecht; Jidnyasa Ingale; Lifei Yang; Mike Hasenberg; Richard T Wyatt; Karola Vorauer-Uhl; Klaus Überla; Vladimir Temchura
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.